Research ArticleOncology
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, Cécile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger and Oliver Langer
Journal of Nuclear Medicine April 2019, 60 (4) 486-491; DOI: https://doi.org/10.2967/jnumed.118.216432
Martin Bauer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Rudolf Karch
2Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria
Beatrix Wulkersdorfer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Cécile Philippe
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
Lukas Nics
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
Eva-Maria Klebermass
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
Maria Weber
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Stefan Poschner
4Department of Clinical Pharmacy and Diagnostics, University of Vienna, Vienna, Austria
Helmuth Haslacher
5Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria
Walter Jäger
4Department of Clinical Pharmacy and Diagnostics, University of Vienna, Vienna, Austria
Nicolas Tournier
6IMIV, CEA, INSERM, CNRS, Université Paris-Sud, Université Paris Saclay, CEA-SHFJ, Orsay, France
Wolfgang Wadsak
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
7Center for Biomarker Research in Medicine, CBmed GmbH, Graz, Austria; and
Marcus Hacker
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
Markus Zeitlinger
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Oliver Langer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
3Division of Nuclear Medicine, Department of Biomedical Imaging und Image-Guided Therapy, Medical University of Vienna, Vienna, Austria
8Center for Health and Bioresources, Austrian Institute of Technology GmbH, Seibersdorf, Austria
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 60, Issue 4
April 1, 2019
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, Cécile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer
Journal of Nuclear Medicine Apr 2019, 60 (4) 486-491; DOI: 10.2967/jnumed.118.216432
A Proof-of-Concept Study to Inhibit ABCG2- and ABCB1-Mediated Efflux Transport at the Human Blood–Brain Barrier
Martin Bauer, Rudolf Karch, Beatrix Wulkersdorfer, Cécile Philippe, Lukas Nics, Eva-Maria Klebermass, Maria Weber, Stefan Poschner, Helmuth Haslacher, Walter Jäger, Nicolas Tournier, Wolfgang Wadsak, Marcus Hacker, Markus Zeitlinger, Oliver Langer
Journal of Nuclear Medicine Apr 2019, 60 (4) 486-491; DOI: 10.2967/jnumed.118.216432
Jump to section
Related Articles
Cited By...
- ABCB1 and ABCG2 Regulation at the Blood-Brain Barrier: Potential New Targets to Improve Brain Drug Delivery
- Pharmacokinetic Imaging with Radiolabeled Molecularly Targeted Anticancer Drugs
- ABCG2- and ABCB1 Inhibition Using Supratherapeutic Doses of Erlotinib: Clinical Implications in the Treatment of Central Nervous System Metastases